Verified peer comparison
iRadimed vs ALX Oncology Holdings Financial Comparison
Direct answer
iRadimed and ALX Oncology Holdings are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free iRadimed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- iRadimed Revenue
- 83,814,000 USD
- ALX Oncology Holdings Revenue
- 0 USD
- iRadimed Operating income
- 26,147,000 USD
- ALX Oncology Holdings Operating income
- -104,021,000 USD